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Although correlations between RNA polymerase II
(RNAPII) transcription stress, R-loops, and genome
instability have been established, the mechanisms
underlying these connections remain poorly under-
stood. Here, we used a mutant version of the tran-
scription elongation factor TFIIS (TFIISmut), aiming
to specifically induce increased levels of RNAPII
pausing, arrest, and/or backtracking in human cells.
Indeed, TFIISmut expression results in slower elonga-
tion rates, relative depletion of polymerases from the
end of genes, and increased levels of stopped
RNAPII; it affects mRNA splicing and termination as
well. Remarkably, TFIISmut expression also dramati-
cally increases R-loops, which may form at the ante-
rior end of backtracked RNAPII and trigger genome
instability, including DNA strand breaks. These re-
sults shed light on the relationship between tran-
scription stress and R-loops and suggest that
different classes of R-loops may exist, potentially
with distinct consequences for genome stability.
INTRODUCTION
In contrast to ATP-drivenmolecular machines such as helicases,
RNA polymerase (RNAP) moves by Brownian motion and may
oscillate between productive and backtracked states at various
positions on DNA. Transcript elongation is therefore an interrup-
ted process, which includes pausing, backtracking, and arrest
(Nudler, 2012) (hereafter often collectively referred to as tran-
scription stress). Although the frequency of such interruption
may be low at any individual nucleotide addition site, it must
be extremely frequent across the genome. Indeed, deep
sequencing of the 30 ends of nascent RNA isolated with
RNAPII elongation complexes (NET-seq) suggested the exis-
tence of >2 3 105 detectable pause sites in the compact yeastMolecular Cell 76, 57–69, O
This is an open access article undgenome, of which more than 75% were associated with a back-
tracked polymerase (Churchman and Weissman, 2011). During
backtracking, the active site of RNAPII loses control of the
RNA 30 end, which is exuded through a channel below the active
site (Kettenberger et al., 2003; Wang et al., 2009).
Backtracked RNAPII is recognized by transcription factor
TFIIS (encoded by DST1 in the yeast Saccharomyces cerevisiae
and TCEA1-3 in humans; the functional analogs are GreA and B
in bacteria) (Nudler, 2012), which stimulates transcript cleavage
by the polymerase active site, thus allowing RNAPII to regain
control of the RNA end and resume transcript elongation (Izban
and Luse, 1992; Kettenberger et al., 2003; Reines, 1992). Back-
tracking and transcript cleavage are an integral part of the elon-
gation process, although the likelihood of it occurring is greatly
increased by any obstacle to forward translocation, such as
nucleotide mis-incorporation, DNA sequences that are difficult
to transcribe, nucleosomes, or other DNA-associated factors in
the path of RNAPII, including other polymerases (see, for
example, Kireeva et al., 2005; Saeki and Svejstrup, 2009; Si-
gurdsson et al., 2010).
In the absence of transcript cleavage, the ability of back-
tracked RNAPII to resume transcription is greatly perturbed,
which has obvious detrimental effects on transcript elongation it-
self, but it has also been proposed that backtracked RNAPII is
particularly problematic for the maintenance of genome stability
(Garcı´a-Muse and Aguilera, 2016; Nudler, 2012). Most evidence
for this idea has been obtained from studies in bacteria or
through experiments in eukaryotic cells that only addressed
the issue indirectly. For example, Nudler and colleagues pro-
vided evidence that genome instability caused by co-directional
transcription-replication collision depends on RNAP backtrack-
ing in Escherichia coli (Dutta et al., 2011). Transcript-cleavage-
defective (Gre-deficient) bacterial cells thus have elevated muta-
tion and recombination rates, and their survival depends on the
SOS response and error-prone double-strand break (DSB) repair
(Dutta et al., 2011; Poteete, 2011). In yeast, the gene encoding
TFIIS was uncovered in functional genomics screens for genome
instability, with its deletion giving rise to a 10-fold increase in
gross chromosomal rearrangement (Putnam et al., 2012),
through unknown mechanisms.ctober 3, 2019 ª 2019 The Author(s). Published by Elsevier Inc. 57
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A study in human cells suggested that TCEA1 depletion may
lead to decreased cell proliferation and apoptosis (Hubbard
et al., 2008). Somewhat surprisingly, however, both bacteria
and yeast lacking the genes encoding their transcript cleavage
factors are viable. In all likelihood, the lack of obvious growth de-
fects indicates an important role for the intrinsic (unstimulated)
cleavage activity of the RNAP active site. This idea is supported
by work in S. cerevisiae, which showed that double mutation of
D290 and E291 (to alanine) in the acidic loop (domain III) of TFIIS
(TFIISmut) is lethal and that overexpression of TFIISmut in a wild-
type (WT) background results in a cessation of growth as well
(Sigurdsson et al., 2010). Importantly, these mutations not only
abrogate normal TFIIS-mediated stimulation of RNAPII-medi-
ated transcript cleavage in the backtracked state but also inhibit
the intrinsic cleavage activity of RNAPII (Sigurdsson et al., 2010).
More recent enzymatic and biochemical studies showed that
TFIISmut also enhances natural pauses, so that RNAPII spends
more time in a backtracked, pre-translocated step during elon-
gation (Imashimizu et al., 2013). Irrespective of the precise un-
derlying mechanism, TFIISmut thus specifically impedes the
rescue of polymerase molecules experiencing transcription
stress, ‘‘trapping’’ such RNAPIIs in their backtracked or paused
states. It is worth noting that TFIIS also has a role during tran-
scriptional initiation (Guglielmi et al., 2007; Kim et al., 2007;
Prather et al., 2005). Importantly, however, this function does
not involve transcript cleavage (Guglielmi et al., 2007); TFIISmut
thus only affects transcript elongation, not transcriptional initia-
tion (Sigurdsson et al., 2010).
Given the well-defined and specific effect of TFIISmut on tran-
script elongation, we examined the consequences of its expres-
sion on a genome-wide scale in human cells. Remarkably, we
show that induction of transcription stress via TFIISmut results
in accumulation of RNA-DNA hybrids (R-loops) and increased
genomic instability due to such structures.
RESULTS
TFIISmut as a Tool to Study the Effects of Transcription
Stress
Yeast TFIISmut is incapable of supporting transcript cleavage by
RNAPII in vitro, and its expression in cells gives rise to transcrip-Figure 1. TFIISmut Interacts with RNAPII and Elicits Transcription Stres
(A) Top: schematic of the in vitro approach. Bottom: autoradiogram of denaturin
(B) Competition experiment, in which different amounts of TFIISmut were used to
denaturing PAGE analysis.
(C) Left: schematic of the approach. Right: incubation of TECs, in the absence of N
the TEC with TFIISmut for the indicated times, the position of RNAPII was determ
backtracked positions, Cs1 and Cs2, are indicated by arrows (Cs2 is quantified
control. Similarly, lane 11 is a control incubation with TFIISmut, but again, no WT
(D) Top: schematics of a cell system to investigate the effect of TFIISmut expression
The lower band in the TFIIS blot is untagged, endogenous TFIIS. Vinculin is show
(E) Western blot showing mono- and polyubiquitylation of RNAPII (Rpb1 subunit)
DSK2 pull-down.
(F) Left: colony-forming ability of TFIISmut-expressing cells, determined by crystal
SEM (bars) values are shown. p values were determined by unpaired t test.
(G) Western blot analysis of TFIISmut-FLAG immunoprecipitation.
(H) Interaction heatmap, based on intensity based absolute quantification (IBAQ
after immunoprecipitation of TFIISmut-FLAG (left) or endogenous RNAPII (right) frtion stress and a dominant-negative effect on growth (Si-
gurdsson et al., 2010). To investigate if similar effects are
observed in human cells, the point mutations that charac-
terize yeast TFIISmut were made in human TCEA1, generating
TCEA1mut (encoding human TFIISmut). We first analyzed the
effect in vitro using reconstituted mammalian RNAPII transcrip-
tion elongation complexes (TECs) and purified, recombinant hu-
man TFIIS. Transcript elongation was initially carried out in the
absence of cytidine triphosphate (CTP), resulting in RNAPII stop-
ping at the first guanine in the template. After removal of unincor-
porated nucleotide triphosphates (NTPs), RNAPII was allowed to
spontaneously backtrack and transcript cleavage was induced
by incubation with TFIIS (Figure 1A, upper). As expected, tran-
script cleavage by RNAPII was strongly stimulated by WT TFIIS
protein, with full-length RNA disappearing and shorter transcript
cleavage products appearing (Figure 1A, lane 3), but TFIISmut
failed to stimulate such cleavage (lane 4), indicating that
RNAPII cannot be effectively rescued from backtracking in the
presence of this form of TFIIS.
To investigate the effect of TFIISmut on the activity of the WT
enzyme, different amounts of TFIISmut were incubated with
nucleotide-depleted, arrested TECs for 10min, followed by addi-
tion of various amounts of WT TFIIS (Figure 1B). Only a large
excess of TFIISmut affectedWT-TFIIS-mediated transcript cleav-
age, suggesting that TFIISmut is a readily exchanging inhibitor,
which does not irreversibly trap RNAPII in an inactive state.
Yeast TFIISmut inhibits intrinsic RNAPII transcript cleavage
(Sigurdsson et al., 2010) and also enhances natural pauses (Im-
ashimizu et al., 2013) so that RNAPII spendsmore time in a back-
tracked, pre-translocated step during elongation. To investigate
whether this might result in TFIISmut effectively promoting further
backtracking of RNAPII because only forward translocation is
impeded, arrested mammalian TECs were incubated with hu-
man TFIISmut over time, before the position of the RNAPII active
site was determined by a brief addition of WT TFIIS to induce
transcript cleavage (Figure 1C). Characterization by denaturing
PAGE showed two primary, backtracked positions (Cs1 and
Cs2), and although RNAPII backtracked to a significant extent
even in the absence of TFIIS, TFIISmut clearly enhanced
RNAPII backtracking to these positions (Figure 1C, compare
Cs1 and Cs2 between lanes 3–6 and 7–10). No intrinsics
g PAGE gel of transcript cleavage by different forms of TFIIS.
inhibit transcript cleavage induced by WT TFIIS in an 8-min incubation prior to
TPs, with TFIISmut to test the effect on RNAPII backtracking. After incubation of
ined by inducing transcript cleavage with WT TFIIS for 3 min. Two prominent
below). Lane 2 is a 90-min incubation without TFIISmut, and no WT TFIIS, as a
TFIIS was added.
. Bottom: western blot analysis of doxycycline-induced expression of TFIISmut.
n as a loading control.
after enrichment of ubiquitylated proteins by glutathione S-transferase (GST)-
violet staining. Right: quantification of the colony-forming assay (n = 3). Mean ±
) values, showing TFIIS and RNAPII subunits identified by mass spectrometry
om the TFIISmut-expressing cell line.
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RNAPII-mediated transcript cleavage was observed even after
90 min in the absence of TFIIS (Figure 1C, lane 2). We were un-
able to detect the intrinsic transcript cleavage activity of
mammalian RNAPII in our experimental system, which pre-
cluded a direct investigation of TFIISmut’s inhibitory activity of
it. TFIISmut did not appear to significantly affect pyrophos-
phate-induced transcript cleavage (Figure S1), which is arguably
unsurprising, given that it is a poor inhibitor even of WT-TFIIS-
induced transcript cleavage.
TFIISmut Expression in Human Cells
In order to establish a system for cellular expression of TFIISmut,
we generated a human cell line in which TCEA1mut was placed
under the control of a doxycycline-inducible promoter, allowing
its moderate overexpression (Figure 1D). Such expression re-
sulted in RNAPII poly-ubiquitylation (Figure 1E), reflecting the
expected increase in transcription stress and likely degradation
of RNAPII in a subset of persistently backtracked TECs.
Given the relatively modest level of TFIISmut expression (Fig-
ure 1D), and given that TFIISmut is a readily exchanging inhibitor
(Figure 1B), the effects on cell viability might be expected to be
limited. However, we noticed that upon TFIISmut expression,
growth rates declined with time, especially under conditions of
low cell density. In order to better assess this effect, we per-
formed colony formation assays. After 11 days of TFIISmut over-
expression, only a few colonies were observed (Figure 1F). This
shows that, similar to yeast (Sigurdsson et al., 2010), the TFIISmut
protein has a negative effect on cell growth and viability. For sub-
sequent experiments, induction of TFIISmut was carried out for
48 h before experimental analysis; at this point, cells grew nor-
mally and showed no outward signs of distress.
We also wanted to ensure that TFIISmut does not have a funda-
mentally altered interaction with RNAPII. We therefore per-
formed immunoprecipitation of either FLAG-tagged TFIISmut or
endogenous RNAPII from the solubilized chromatin fraction of
a nuclear extract. Western blot analysis of the TFIISmut immuno-
precipitates confirmed the specificity of the interaction (Fig-
ure 1G), and the protein samples were subjected to mass spec-
trometry analysis (Table S1). This revealed that the interaction
between TFIISmut and RNAPII is not significantly altered, and
only a marginal increase in the overall level of interaction with
RNAPII was observed in chromatin upon TFIISmut overexpres-
sion (Figure 1H). This suggests that TFIISmut competes with the
WT protein for association with ‘‘stressed’’ RNAPII during tran-
script elongation.
TFIISmut Pauses RNAPII in the Gene Body
TFIIS dynamically associates with paused or backtracked
RNAPII. As suggested by the in vitro data of Figures 1A–1C,
expression of TFIISmut would thus be expected to trap RNAPIIs
experiencing transcription stress, prolonging pausing and
lengthening backtracks stochastically across genes. To investi-
gate the consequences of such events inside cells, we first per-
formed RNAPII chromatin immunoprecipitation sequencing
(ChIP-seq) analysis. Upon TFIISmut overexpression, numerous
genes, such as TP53, showed increased RNAPII occupancy in
the coding region, suggesting problems with transcript elonga-
tion (Figure 2A). No obvious features, such as gene length or60 Molecular Cell 76, 57–69, October 3, 2019DNA sequence motifs, were in common among the most
affected genes.We also used 5-ethynyl uridine (5-EU) incorpora-
tion to measure nascent RNA synthesis. Time-course analysis
revealed that in TFIISmut-expressing cells, the overall rate of
RNA synthesis is reduced (Figures 2B and S2A).
To further investigate the effect of TFIISmut on transcription
genome-wide, we employed a modified version of 4-thiouridine
sequencing (TT-seq) (Schwalb et al., 2016), which allows mea-
surements of nascent RNA synthesis at high genomic resolution.
Cells were metabolically labeled with 4-thiouridine (4SU) for
20 min, allowing the subsequent separation of recently tran-
scribed RNA from the overall RNA population, before RNA frag-
mentation, library production, and deep sequencing (Gregersen
et al., 2019) (see STAR Methods for details). The results from the
ROBO2 gene is shown as an example (Figure 2C; see also Fig-
ure S2B); RNAPII activity was fairly equally distributed across
the gene in parental cells but was relatively depleted toward
the 30 end in cells expressing TFIISmut. Meta-gene profiles re-
vealed that this was a general effect, as indicated by the concen-
tration of RNAPII activity in the first third of genes (Figure 2D, left).
Not surprisingly, this was more clearly observed in long genes
(Figure 2D, right).
We also used the CDK9- and transcription elongation inhibitor
5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) in combi-
nation with nascent RNA analysis (4SU incorporation), as a
variant of DRB/global run-on (GRO) analysis (Saponaro et al.,
2014) to analyze RNAPII elongation. Upon release from DRB in-
hibition, cells were incubated at different time points with 4SU for
10min (Figure S2C, top). Total 4SU incorporation was decreased
at a global level, which was most easily observed 10 min after
DRB release (Figure S2C, bottom). Single-gene analysis of
RNAPII progression was then carried out for the long OPA1
gene, with nascent RNA levels measured by qRT-PCR using
primers that spanned the length of the gene every 5 kb. After
40 min of transcript elongation, a markedly lower level of
RNAPII activity was observed toward the end of the gene in
TFIISmut-expressing cells (Figure S2D), indicating that RNAPII
on average takes longer to run into this area of the gene when
transcript cleavage is inhibited by TFIISmut expression.
Taken together, the results from the different genome-wide
and gene-specific analyses described above support the idea
that inducing transcription stress via TFIISmut results in a global
reduction of nascent RNA synthesis and slower average elonga-
tion across genes, in all likelihood caused by increasing the time
spent by RNAPII in pause and backtracking mode.
Changes in Gene Expression and Splicing in Response
to TFIISmut Expression
mRNA processing is tightly coupled to elongation, with mRNA
processing factors likely being deposited by RNAPII so that
slow elongation may affect alternative cassette exons splicing
and termination (Dujardin et al., 2013). We therefore also investi-
gated the effect that TFIISmut expression has on mRNA process-
ing by deep sequencing of libraries generated from mRNA.
First, although several genes were differentially expressed in
the TFIISmut-expressing cells compared to control, the differ-
ences were modest (Figure S3A; Table S2). Tellingly, however,
the median length of the 124 upregulated genes was 18.1 kb,
Figure 2. TFIISmut Pauses RNAPII in the Gene Body
(A) Effect of TFIISmut expression on the RNAPII ChIP-seq profile at the TP53 gene. TSS, transcription start site.
(B) Line plots of mean average 5-EU intensity of nascent RNA labeled for different times with and without TFIISmut expression. Bars represent ±SEM. p values
were determined by two-way ANOVA statistical test.
(C) Representative example of the TT-seq profile, across the ROBO2 gene. Notice the relative accumulation of 50 end reads in the TFIISmut-expressing cells.
Another example is shown in Figure S2B.
(D) Metagene TT-seq profile of all transcripts (left) and of long transcripts (>60 kb, right) anchored by 50 end (0%) and 30 end (100%) of genes of TT-seq for two
biological replicates.while that of the 145 downregulated genes was no less than
193.8 kb (Figure S3B), again underscoring the selective effect
of TFIISmut on transcript elongation.
Second, in order to quantitatively measure the relative expres-
sion of transcript isoforms (mRNA splicing), we used the mixture
of isoform (MISO) model (Katz et al., 2010). Relative to parental
cells, hundreds of splicing events were affected by TFIISmutexpression (Table S3), but with relatively few changes in cassette
exon splicing and with alternative last exon (ALE) events being
among the most frequent, accounting for approximately one-
third of all splicing events recorded in all three replicates (Fig-
ure 3A). ALE transcript isoforms are characterized by differential
30 terminal exon usage; i.e., they are mechanistically a conse-
quence of alternative transcriptional termination. We analyzedMolecular Cell 76, 57–69, October 3, 2019 61
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the common ALE events from all three biological replicates and
observed a consistent, relative upregulation of shorter transcript
isoforms (Figure 3B). The relative expression of the isoforms of
two gene examples, CNTLN, which was among the genes that
showed upregulation of a shorter isoform, and ASCC3, which
was identified by manual inspection as an additionally affected
gene, is shown in Figure 3C; qRT-PCR experiments confirmed
the results at those genes (Figure 3D). Interestingly, these results
suggested that the relative upregulation of short isoformsmay be
caused by a relative failure of RNAPII to reach the end of these
long genes (i.e., loss of the long isoforms), presumably through
a decrease in RNAPII processivity rather than an increase in
the short isoforms per se.
We conclude that TFIISmut expression affects gene expression
at long genes and that it, not unexpectedly, also affects mRNA
splicing and termination.
Expression of TFIISmut Leads to Increased R-Loop
Formation
Several kinds of transcription perturbation can result in the accu-
mulation of R-loops in eukaryotic cells (Santos-Pereira and Agui-
lera, 2015), but whether transcriptional pausing and backtrack-
ing can induce them has not been directly investigated. We
therefore next analyzed if TFIISmut expression results in the accu-
mulation of such DNA-RNA hybrids. Interestingly, slot blot anal-
ysis of isolated genomic DNA using the hybrid-specific S9.6 anti-
body revealed a clear increase in RNase-H-sensitive R-loops
after TFIISmut expression (Figures 4A and 4B). We also used
the S9.6 antibody to detect R-loops by immunostaining of these
cells. As expected from the data in Figures 4A and 4B, nucleo-
plasmic R-loop staining intensity was consistently markedly
higher in the TFIISmut-expressing cells (Figures S4A and S4B).
We also used DNA-RNA immunoprecipitation (DRIP) to inves-
tigate the accumulation of R-loops at individual genes. We first
investigated some of the genes that have previously been shown
to accumulate R-loops, such as APOE, RPL13A, and BTBD19
(Bhatia et al., 2014; Ginno et al., 2013; Herrera-Moyano et al.,
2014) (Figure S4C). A consistent trend in R-loop accumulation
at these genes was observed in TFIISmut-expressing cells, and,
importantly, RNase H treatment again abolished this accumula-
tion. Utilizing our previously generated RNAPII ChIP-seq data
(Figure 2), we also identified a further gene with R-loop accumu-
lation based on two criteria: first, we filtered for genes that had
markedly increased RNAPII density in the gene body by ChIP,
suggesting many backtracked and/or stalled RNAPIIs, and, sec-
ond, we identified the subset of those genes that also havemany
or large CpG islands, as R-loops often form in CG-rich regions
(Ginno et al., 2012). The SOX4 gene convincingly met both
criteria (Figure S4D) and, gratifyingly, DRIP-qPCR analysis
showed marked R-loop accumulation at this gene as well (Fig-Figure 3. Alternative Last Exon Splicing in TFIISmut Cells
(A) mRNA isoform expression-changes in TFIISmut-expressing cells detected by
splice site; A5SS, alternative 50 splice site; MXE, mutually exclusive exons; RI, re
(B) Relative expression differences of terminal exons associated with common AL
calculated for the TFIISmut sample and normalized to that in parental cells.
(C) Representative examples of ALE events in RNA-seq profiles (top, ASCC3; bo
(D) qRT-PCR validation of isoform expression. GAPDH-normalized and relative ture 4C). By contrast, the SNRPN gene has previously been
shown by others to not accumulate R-loops (Bhatia et al.,
2014; Herrera-Moyano et al., 2014) and was used as a negative
control for these results (Figure 4D).
R-loops are generally thought to arise by re-annealing of the
nascent RNA transcript with the DNA template behind the elon-
gating polymerase. Indeed, disruption of factors that are impor-
tant for packaging of the nascent RNA into mRNP particles often
gives rise to significant R-loop accumulation (Santos-Pereira
and Aguilera, 2015). Although an effect on RNA packaging
cannot be ruled out, TFIISmut expression would not be expected
to affect such transactions. Instead, it would be predicted to trap
backtracked RNAPII and potentially stimulate further backtrack-
ing and thus potentially result in the formation of R-loops via
nascent RNA that is in front of the polymerase. Alternatively,
backtracked RNAPII might be dissociated or degraded, poten-
tially leaving the released, nascent RNA to form R-loops. Directly
investigating whether R-loops form anterior or posterior to
RNAPII in vivo is unfortunately not possible with presently
available techniques, so we instead set out to test if an effect
of TFIISmut on R-loop formation could be observed with pure
proteins in vitro. For this purpose, we used the previously
described in vitro transcription assay, this time with a template
in which RNAPII elongated from a radio- or fluorescent-labeled
RNA oligonucleotide up to a position with an adenine in the cod-
ing strandwhere it stopped, because no UTPwas included in the
reaction (generating a 76-nt transcript) (Figure 4E, left). Because
the signal from these reactions was very weak, we used themore
active yeast RNAPII for these experiments. After removal of un-
incorporated NTPs, backtracking (and potentially R-loop forma-
tion) was stimulated through the addition of TFIISmut (and WT
TFIIS as control). RNase H was then used to assess if R-loops
were formed. Characterization by denaturing PAGE showed
that the RNA behind the elongating RNAPII generated few, if
any, R-loops under these conditions (Figure 4E, right; compare
lanes 1 and 2). Upon removal of nucleotides and the addition
of TFIISmut to allow backtracking, but not transcript cleavage, a
weak smear of fragments of a smaller size were visible only in
the RNase-H-treated sample, suggesting that R-loops were
formed by RNA in front of the backtracking polymerase (Fig-
ure 4E, compare lanes 7 and 8). The conclusion that these
RNase-H-generated RNA products were anterior R-loops was
further strengthened by purification of the TECs after RNase H
cleavage, which removes the label from the RNA of posterior
R-loops (Figure 4F, compare lanes 6 and 9 with lane 3; see
also Figure S5 for detailed description of this experiment). As ex-
pected, no anterior R-loops were detected in the samples incu-
bated with cleavage-inducing WT TFIIS, because the transcripts
in these conditions are continuously cleaved as the polymerase
moves backward (Figure 4E, lanes 5 and 6; and Figure 4F, lanesMISO analysis of mRNA-seq. A3SS, ALE, alternative last exon, alternative 30
tained exon; SE, skipped exons.
E events induced by transcript cleavage inhibition. The ratio to distal exon was
ttom, CNTLN).
o parental conditions (n = 3). Mean ± SEM (bars) values are shown.
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11 and 12). Importantly, a small but detectable signal was
observed in the samples in which no TFIIS was added (compare
Figure 4E, lanes 3 and 4; and Figure 4F, lane 1 versus lane 3),
together suggesting that R-loop formation is intrinsic to the
backtracking polymerase rather than specific to the conditions
where TFIISmut is present. The fragments produced by RNase
H were 30–40 nt, in agreement with the expectations from the
RNAPII ‘‘footprint’’’ (see Figure S5).
Together, these results are consistent with the idea that
R-loops accumulate in cells that have defects in transcript cleav-
age, caused at least partly by retrograde sliding of RNAPII, which
allows hybridization of the nascent RNAwith the DNA template in
front of the polymerase, generating anterior R-loops.
R-Loops Give Rise to Genome Instability in TFIISmut-
Expressing Cells
We finally investigated the impact of TFIISmut expression and
R-loop formation on genome stability. We initially assayed the ef-
fect of TFIISmut expression by detection of phosphorylated H2AX
(gH2AX) as a general marker for DNA damage. Upon overex-
pression of TFIISmut to induce transcription stress, an increase
in chromatin-bound levels of gH2Ax was observed by western
blotting (Figure 5A). These results provided the first indica-
tions that the increase in pausing and backtracking caused by
TFIISmut expression affects genome stability.
Given these results, we now tested the effect of TFIISmut
expression on the levels of 53BP1, a marker of DNA DSBs
(Schultz et al., 2000). TFIISmut-expressing HEK293 cells showed
a clear increase in the general staining levels of 53BP1 (Fig-
ure 5B). Unfortunately, the HEK293 cells are not suitable for mi-
croscopy analysis. For this reason, and also to investigate the
phenomenon in an independent cell line, we used U2OS cells
for most of the remaining experiments. In these assays, we tran-
siently expressed TFIISmut and then quantified the accumulation
of 53BP1 foci. Gratifyingly, 53BP1-foci-containing cells were
clearly increased upon expressing TFIISmut, and this was
repressedby concomitant RNaseH1overexpression (Figure 5C),
indicating that genome instability was caused by R-loop accu-
mulation. For further evidence of the accumulation of DNA
breaks in an R-loop-dependent manner, we directly analyzed
the accumulation of DNA strand breaks by single-cell gel electro-
phoresis (Comet assay) (Collins, 2004). We performed this assay
under alkaline conditions to detect both double- and single-
stranded DNA breaks. In these assays, expression of TFIISmut
led to a larger tail moment than control cells, and this effect couldFigure 4. TFIISmut Expression Results in an Accumulation of R-Loops
(A) RNA or DNA hybrid slot-blot of genomic DNA from TFIISmut and parental cells,
on right) with single-strand DNA antibody (bottom panel) as a loading control. Se
standards (left panel).
(B) Fold enrichment in RNA or DNA hybrids compared with control (n = 3). Mean
(C and D) DRIP-qPCR analysis of R-loop induction at the SOX4 gene (C) and the
determined by two-way ANOVA statistical test.
(E) Left: schematic of idealized experiment. Radioactive label is denoted by red dot
transcript is also indicated. Right: R-loop detection by denaturingPAGE after additi
size markers are indicated on the left for approximate RNA sizes. Positions of full-
(F) Left: experimental scheme; similar to that of (E) but involving purification via the
after addition of TFIIS proteins and RNase H to yeast TECs assembled in vitro. App
next to relevant lanes. Asterisk-bar denotes irrelevant pausing sites of unknown oagain be suppressedby overexpression of RNaseH1 (Figure 5D),
suggesting that transcription stress-induced R-loops result in
DNA strand breaks.
We previously used comparative genomic hybridization
(CGH) to show that chromosomal rearrangements can occur
in response to certain kinds of transcription stress, such as after
RECQL5 or MLL2 perturbation (Kantidakis et al., 2016; Sapo-
naro et al., 2014). This technique compares different genomic
DNA samples for genomic changes such as gains or losses of
chromosomal regions or whole chromosomes (Park, 2008).
TFIISmut-expressing HEK293 cells were grown in the absence
of doxycycline, and the batch was then split in two and grown
either in the continued absence of doxycycline or in the pres-
ence of it to induce TFIISmut overexpression. Genomic DNA
preparations from the two cell populations were then compared
by CGH. Interestingly, we detected no genomic rearrangement
upon TFIISmut expression, either after 48 h or after 7 days of
induction.
Altogether, these results suggest that R-loops form and accu-
mulate when transcription elongation is perturbed by inhibiting
transcript cleavage, leading to genomic instability, as evidenced
by the accumulation of single- and double-stranded DNA
breaks. However, this does not appear to result in gains or losses
of whole chromosomes or chromosomal regions that are occur-
ring extensively and repeatedly enough to be detectable
by CGH.
DISCUSSION
Most of our understanding of RNAPII backtracking and TFIIS-
mediated transcript cleavage comes from biochemical and
structural studies (Fish and Kane, 2002). However, in yeast cells,
most detectable pause sites are associated with backtracked
RNAPII complexes (Churchman and Weissman, 2011), and it is
therefore important to build on the biochemical insight to under-
stand the mechanisms by which cells deal with backtracked and
stopped RNAPII. Here, we used amutant form of TFIIS (TFIISmut)
to study the consequences of trapping RNAPII in an inactive,
paused, or backtracked state in human cells. Our study provides
new insight into the effect on RNAPII transcript elongation when
transcript cleavage is inhibited, as well as important new infor-
mation on R-loop biology. Most notably, we find that increased
RNAPII pausing and backtracking results in R-loop formation
and genome instability, providing a direct link between transcrip-
tion stress, R-loop formation, and DNA damage.±RNase H. S9.6 antibody was used to detect RNA or DNA hybrids (upper panel
rial dilutions of genomic DNA (1/1 = 4 mg) were probed with S9.6 antibody for
± SEM (bars) values are shown. p values were determined by unpaired t test.
SNRPN gene (D) (n = 3). Mean ± SEM (bars) values are shown. p values were
and the biotin tag onDNAwith a black dot. The position of the first adenine in the
on of TFIIS proteins andRNaseH to yeast TECs assembled in vitro. AmbionRNA
length product (FL), R-loops, and cleavage products are indicated on the right.
biotin tag after RNase H digestion. Right: R-loop detection by denaturing PAGE
roximate RNA sizes RNA and position of R-loops are indicated on the right and
rigin, including IC1 and IC2. See Figure S5 for detailed schematic explanations.
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Figure 5. TFIISmut Induces R-Loop-Dependent DNA Damage
(A) Western blot analysis of the chromatin fraction after overexpression of TFIISmut, showing gH2Ax levels. Histone H2Ax is shown as a loading control.
(B) Left: immunofluorescence of TFIISmut-expressing cells, stained with antibodies against 53BP1. Right: quantification of average nuclear intensity. p values
were determined by unpaired t test.
(C) Left: immunofluorescence of U2OS cells transiently transfected with TFIISmut plasmid, stained with antibodies against 53BP1, ±doxycycline-inducible RNase
H1 expression. Right: percentage of cells with more than 5 foci. Mean ± SEM values from at least five independent experiments are shown. p values were
determined by unpaired t test.
(D) Quantification of DNA breaks after transfection with TFIISmut assessed by the alkaline comet assay ±RNase H1. Mean ± SEM values from seven independent
experiments are shown. p values were determined by unpaired t test.
(E) Model for the genesis of different kinds of R-loops in cells.Expression of TFIISmut in human cells affects transcript elon-
gation and cell viability, in agreement with our previous results
in yeast (Sigurdsson et al., 2010). Clear evidence for an average66 Molecular Cell 76, 57–69, October 3, 2019transcriptional slow-down is observed, including a relative
depletion of RNAPII toward the end of genes and effects on
co-transcriptional processing, including mRNA splicing and
termination. At the level of gene expression, this has the conse-
quence that long genes are more negatively affected, with the
average length of the downregulated genes being almost 200
kb, while that of the upregulated genes is less than 20 kb. Taken
together, our data thus support a crucial role for transcript cleav-
age in supporting transcript elongation in human cells. These re-
sults complement recently published data by the Bentley labora-
tory using the same TFIIS mutant (Sheridan et al., 2019).
During backtracking, the active site of RNAPII loses control of
the RNA 30 end, which is extruded through a channel below the
active site (Cheung and Cramer, 2011; Wang et al., 2009). Tran-
scription problems resulting in backtracking will occur in a sto-
chastic fashion across the genome, but due to the existence of
TFIIS and intrinsic transcript cleavage by RNAPII, such back-
tracks are, on average, likely to be relatively short-lived. Back-
tracks are thus individually random and rare but statistically
predictable and globally very frequent. This means that study-
ing the consequence of RNAPII retrograde motion inside cells
is challenging. However, biochemical reconstitution experi-
ments have taught us important, basic properties of RNAPII
backtracking. In the experiments described here, RNAPII was
incubated for extended periods of time in the absence of nucle-
otides to allow a small proportion of elongation complexes to
backtrack the considerable distance required for anterior
R-loops to be able to form. However, during events such as
head-to-tail collision between RNAPIIs, backtracking for a dis-
tance of more than 25 nt is almost instantaneous (Saeki and
Svejstrup, 2009), and despite the fact that RNAPII possesses
intrinsic cleavage activity, it fails to recover efficiently from
backtracks on its own when they are beyond 10 nt (Lisica
et al., 2016). In general, RNAPII ceases to transcribe and is un-
able to recover from backtracks at only one-third of the force
determined for E. coli RNAP (Galburt et al., 2007), suggesting
that the eukaryotic polymerase that transcribes protein-coding
genes is intrinsically obstacle sensitive and prone to get trap-
ped after retrograde motion. It is thus easy to imagine that if
pausing and backtracking is not dealt with quickly inside cells,
then protracted backtracking may take place and the length-
ening, exuded RNA might form an R-loop anterior to the
RNAPII complex. We believe that this situation may hitherto
have been overlooked when considering the genesis and con-
sequences of R-loops, which have invariably been depicted
as occurring to the posterior side of RNAPII (Figure 5E).
While extensive transcription stress may give rise to some
RNAPII dissociation or degradation, potentially allowing the
nascent transcript to invade the DNA template, the results pre-
sented here support the idea that anterior R-loops can accumu-
late in direct response to transcriptional backtracking. Our re-
sults also indicate that R-loops resulting from transcription
stress give rise to genome instability, including DNA strand
breaks. Interestingly, CGH analysis failed to uncover gains or
losses of whole chromosomes or chromosomal regions resulting
from these DNA breaks. It is presently unclear whether the sto-
chastic nature of RNAPII backtracking means that any gains or
losses are not occurring extensively and repeatedly enough in
the same regions to be detectable by CGH or if the strand breaks
occurring in response to R-loop formation in TFIISmut-expressing
cells are simply (invariably) precisely repaired.Previous work indicated that genome instability observed
after depletion of factors such as the THO complex, splicing
factor SRSF1, DDX23, SETX, DHX9, TOP1, and many others
is caused by R-loops as well (see, for example, Domı´nguez-
Sa´nchez et al., 2011; Groh et al., 2017; Huertas and Aguilera,
2003; Li and Manley, 2005; Manzo et al., 2018; Skourti-Stathaki
et al., 2011; Sridhara et al., 2017; Tuduri et al., 2009). Defects in
these factors have been presumed to result in R-loops poste-
rior to RNAPII, but whether and how these R-loops relate to
those caused by TFIISmut expression remains to be investi-
gated. Interestingly, while it was previously shown in E. coli
that DSBs accumulate at sites of co-directional collisions be-
tween the replisome and backtracked elongation complexes
(Dutta et al., 2011), recent studies aimed at addressing the mo-
lecular basis of transcription-replication collisions and their
relationship with genome-destabilizing R-loops concluded
that head-to-head collision of the DNA replication fork with
DNA-RNA hybrids constitutes a particular threat in human
cells, bacteria, and yeast (Garcı´a-Rubio et al., 2018; Hamperl
et al., 2017; Lang et al., 2017). We suggest that the conse-
quence of R-loop-mediated transcription-replication conflicts
may depend on whether the R-loops in question are anterior
or posterior to the RNAP.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d LEAD CONTACT AND MATERIALS AVAILABILITY
d EXPERIMENTAL MODEL AND SUBJECT DETAILSB Cell Lines and Culture Conditions
d METHOD DETAILS
B Generation of Stable Cell Line
B Colony Formation Assay
B Immunofluorescence
B 53BP1 Foci Analysis in U20S
B Alkaline Comet Assay
B Western Blotting
B Flag- and RNAPII-Immunoprecipitation – Extract Prep-
aration
B Flag (M2)-Affinity Purification of TFIIS
B RNAPII Affinity Purification
B DSK2-Pulldown
B 5-Ethynyl Uridine (EU) Transcription Assay
B ChIP-Sequencing
B mRNA-Sequencing
B TT-Seq (Nascent RNA-Seq)
B Reverse Transcriptase Quantitative PCR
B DNA-RNA Slot Blot
B DNA-RNA Hybrid Mapping (DRIP)
B Recombinant Protein Expression and Purification
B Purification of Bovine Pol II
B Oligonucleotides for In Vitro Transcription
B Transcript Cleavage Experiments
B In Vitro R-Loop Formation Experiments
B N-Terminal TFIIS Antibody ProductionMolecular Cell 76, 57–69, October 3, 2019 67
d QUANTIFICATION AND STATISTICAL ANALYSIS
B BigWig Files
B mRNA Differential Expression Analysis
B mRNA-Seq Alternative Isoform Analysis
B TT-Seq Metagene Profiles
d DATA AND CODE AVAILABILITY
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
molcel.2019.07.037.
ACKNOWLEDGMENTS
We thank the Advanced Sequencing Facility, the Proteomics Facility, and the
High Throughput Screening Facility of the Francis Crick Institute (FCI) for their
support and time spent on this project, and we thank Marco Saponaro for his
help with sequencing protocols. This work was supported by the FCI (which
receives its core funding from Cancer Research UK [FC001166], the UK Med-
ical Research Council [FC001166], and the Wellcome Trust [FC001166]), a
grant from the European Research Council (agreement 693327 [TRANSDAM])
(to J.Q.S.), and grants from the European Research Council (grant ERC2014
AdG669898 TARLOOP), the Spanish Ministry of Economy and Competitive-
ness (grants BFU2013-42918-P and BFU2016-75058-P), and the European
Union (Fondo Europeo de Desarrollo Regional) (to A.A.).
AUTHOR CONTRIBUTIONS
D.Z. performed most experiments. Some of the in vitro transcription assays
were performed by Z.H., and the Comet assays and 53BP1 analysis in
U2OS cells were performed by E.T. and S.R. RNAPII and TFIIS purification
was performed by H.W., Z.H., A.B.D.-S., and D.Z. The modified TT-seq proto-
col was developed by L.G., and bioinformatic analysis was performed by R.M.
D.Z. and J.Q.S. wrote the paper, with input from all authors. A.S., A.A., and
J.Q.S. supervised the work.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: October 30, 2018
Revised: May 28, 2019
Accepted: July 26, 2019
Published: September 10, 2019
REFERENCES
Anders, S., Reyes, A., and Huber, W. (2012). Detecting differential usage of
exons from RNA-seq data. Genome Res 22, 2008–2017.
Anindya, R., Ayg€un, O., and Svejstrup, J.Q. (2007). Damage-induced ubiquity-
lation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not
Cockayne syndrome proteins or BRCA1. Mol. Cell 28, 386–397.
Bhatia, V., Barroso, S.I., Garcı´a-Rubio, M.L., Tumini, E., Herrera-Moyano, E.,
and Aguilera, A. (2014). BRCA2 prevents R-loop accumulation and associates
with TREX-2 mRNA export factor PCID2. Nature 511, 362–365.
Cheung, A.C., and Cramer, P. (2011). Structural basis of RNA polymerase II
backtracking, arrest and reactivation. Nature 471, 249–253.
Churchman, L.S., and Weissman, J.S. (2011). Nascent transcript sequencing
visualizes transcription at nucleotide resolution. Nature 469, 368–373.
Collins, A.R. (2004). The comet assay for DNA damage and repair: principles,
applications, and limitations. Mol. Biotechnol. 26, 249–261.
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut,
P., Chaisson,M., andGingeras, T.R. (2013). STAR: ultrafast universal RNA-seq
aligner. Bioinformatics 29, 15–21.68 Molecular Cell 76, 57–69, October 3, 2019Domı´nguez-Sa´nchez, M.S., Barroso, S., Go´mez-Gonza´lez, B., Luna, R., and
Aguilera, A. (2011). Genome instability and transcription elongation impair-
ment in human cells depleted of THO/TREX. PLoS Genet. 7, e1002386.
Dujardin, G., Lafaille, C., Petrillo, E., Buggiano, V., Go´mez Acun˜a, L.I., Fiszbein,
A., Godoy Herz, M.A., Nieto Moreno, N., Mun˜oz, M.J., Allo´, M., et al. (2013).
Transcriptional elongation and alternative splicing. Biochim. Biophys. Acta
1829, 134–140.
Dutta, D., Shatalin, K., Epshtein, V., Gottesman, M.E., and Nudler, E. (2011).
Linking RNA polymerase backtracking to genome instability in E. coli. Cell
146, 533–543.
Fish, R.N., and Kane, C.M. (2002). Promoting elongation with transcript cleav-
age stimulatory factors. Biochim. Biophys. Acta 1577, 287–307.
Galburt, E.A., Grill, S.W., Wiedmann, A., Lubkowska, L., Choy, J., Nogales, E.,
Kashlev, M., and Bustamante, C. (2007). Backtracking determines the force
sensitivity of RNAP II in a factor-dependent manner. Nature 446, 820–823.
Garcı´a-Muse, T., and Aguilera, A. (2016). Transcription-replication conflicts:
how they occur and how they are resolved. Nat. Rev. Mol. Cell Biol. 17,
553–563.
Garcı´a-Rubio, M., Aguilera, P., Lafuente-Barquero, J., Ruiz, J.F., Simon, M.N.,
Geli, V., Rondo´n, A.G., and Aguilera, A. (2018). Yra1-bound RNA-DNA hybrids
cause orientation-independent transcription-replication collisions and telo-
mere instability. Genes Dev. 32, 965–977.
Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S.,
Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004). Bioconductor: open soft-
ware development for computational biology and bioinformatics. Genome
Biol. 5, R80.
Ginno, P.A., Lott, P.L., Christensen, H.C., Korf, I., andChe´din, F. (2012). R-loop
formation is a distinctive characteristic of unmethylated human CpG island
promoters. Mol. Cell 45, 814–825.
Ginno, P.A., Lim, Y.W., Lott, P.L., Korf, I., andChe´din, F. (2013). GC skew at the
50 and 30 ends of human genes links R-loop formation to epigenetic regulation
and transcription termination. Genome Res. 23, 1590–1600.
Gregersen, L.H., Mitter, R., Ugalde, A.P., Nojima, T., Proudfoot, N.J., Agami,
R., Stewart, A., and Svejstrup, J.Q. (2019). SCAF4 and SCAF8, mRNA anti-
terminator proteins. Cell 177, 1797–1813.e18.
Groh, M., Albulescu, L.O., Cristini, A., and Gromak, N. (2017). Senataxin:
genome guardian at the interface of transcription and neurodegeneration.
J. Mol. Biol. 429, 3181–3195.
Guglielmi, B., Soutourina, J., Esnault, C., and Werner, M. (2007). TFIIS elonga-
tion factor andMediator act in conjunction during transcription initiation in vivo.
Proc. Natl. Acad. Sci. USA 104, 16062–16067.
Hamperl, S., Bocek, M.J., Saldivar, J.C., Swigut, T., and Cimprich, K.A. (2017).
Transcription-replication conflict orientation modulates R-loop levels and ac-
tivates distinct DNA damage responses. Cell 170, 774–786.e719.
Herrera-Moyano, E., Mergui, X., Garcı´a-Rubio, M.L., Barroso, S., and Aguilera,
A. (2014). The yeast and human FACT chromatin-reorganizing complexes
solve R-loop-mediated transcription-replication conflicts. Genes Dev. 28,
735–748.
Hu, X., Malik, S., Negroiu, C.C., Hubbard, K., Velalar, C.N., Hampton, B.,
Grosu, D., Catalano, J., Roeder, R.G., and Gnatt, A. (2006). A Mediator-
responsive form of metazoan RNA polymerase II. Proc. Natl. Acad. Sci. USA
103, 9506–9511.
Huang, da W., Sherman, B.T., and Lempicki, R.A. (2009a). Systematic and
integrative analysis of large gene lists using DAVID bioinformatics resources.
Nat Protoc. 4, 44–57.
Huang, da W., Sherman, B.T., and Lempicki, R.A. (2009b). Bioinformatics
enrichment tools: paths toward the comprehensive functional analysis of large
gene lists. Nucleic Acids Res. 37, 1–13.
Hubbard, K., Catalano, J., Puri, R.K., andGnatt, A. (2008). Knockdown of TFIIS
by RNA silencing inhibits cancer cell proliferation and induces apoptosis. BMC
Cancer 8, 133.
Huertas, P., and Aguilera, A. (2003). Cotranscriptionally formed DNA:RNA hy-
brids mediate transcription elongation impairment and transcription-associ-
ated recombination. Mol. Cell 12, 711–721.
Imashimizu, M., Kireeva, M.L., Lubkowska, L., Gotte, D., Parks, A.R.,
Strathern, J.N., and Kashlev, M. (2013). Intrinsic translocation barrier as an
initial step in pausing by RNA polymerase II. J. Mol. Biol. 425, 697–712.
Izban, M.G., and Luse, D.S. (1992). The RNA polymerase II ternary complex
cleaves the nascent transcript in a 30——50 direction in the presence of elon-
gation factor SII. Genes Dev. 6, 1342–1356.
Kantidakis, T., Saponaro, M., Mitter, R., Horswell, S., Kranz, A., Boeing, S.,
Ayg€un, O., Kelly, G.P., Matthews, N., Stewart, A., et al. (2016). Mutation of can-
cer driver MLL2 results in transcription stress and genome instability. Genes
Dev. 30, 408–420.
Katz, Y., Wang, E.T., Airoldi, E.M., and Burge, C.B. (2010). Analysis and design
of RNA sequencing experiments for identifying isoform regulation. Nat.
Methods 7, 1009–1015.
Kent, W.J., Zweig, A.S., Barber, G., Hinrichs, A.S., and Karolchik, D. (2010).
BigWig and BigBed: enabling browsing of large distributed datasets.
Bioinformatics 26, 2204–2207.
Kettenberger, H., Armache, K.J., and Cramer, P. (2003). Architecture of the
RNA polymerase II-TFIIS complex and implications for mRNA cleavage. Cell
114, 347–357.
Kim, B., Nesvizhskii, A.I., Rani, P.G., Hahn, S., Aebersold, R., and Ranish, J.A.
(2007). The transcription elongation factor TFIIS is a component of RNA poly-
merase II preinitiation complexes. Proc. Natl. Acad. Sci. USA 104,
16068–16073.
Kireeva, M.L., Hancock, B., Cremona, G.H., Walter, W., Studitsky, V.M., and
Kashlev, M. (2005). Nature of the nucleosomal barrier to RNA polymerase II.
Mol. Cell 18, 97–108.
Lang, K.S., Hall, A.N., Merrikh, C.N., Ragheb, M., Tabakh, H., Pollock, A.J.,
Woodward, J.J., Dreifus, J.E., andMerrikh, H. (2017). Replication-transcription
conflicts generate R-loops that orchestrate bacterial stress survival and path-
ogenesis. Cell 170, 787–799.e18.
Li, B., and Dewey, C.N. (2011). RSEM: accurate transcript quantification from
RNA-Seq data with or without a reference genome. BMC Bioinformatics
12, 323.
Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with
Burrows-Wheeler transform. Bioinformatics 25, 1754–1760.
Li, X., and Manley, J.L. (2005). Inactivation of the SR protein splicing factor
ASF/SF2 results in genomic instability. Cell 122, 365–378.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G.,
Abecasis, G., and Durbin, R.; Genome Project Data Processing Subgroup
(2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics
25, 2078–2079.
Lisica, A., Engel, C., Jahnel, M., Rolda´n, E´., Galburt, E.A., Cramer, P., and Grill,
S.W. (2016). Mechanisms of backtrack recovery by RNA polymerases I and II.
Proc. Natl. Acad. Sci. USA 113, 2946–2951.
Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta C(T)) Method.
Methods 25, 402–408.
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550.
Manzo, S.G., Hartono, S.R., Sanz, L.A., Marinello, J., De Biasi, S., Cossarizza,
A., Capranico, G., and Chedin, F. (2018). DNA Topoisomerase I differentially
modulates R-loops across the human genome. Genome Biol. 19, 100.Nudler, E. (2012). RNA polymerase backtracking in gene regulation and
genome instability. Cell 149, 1438–1445.
Park, P.J. (2008). Experimental design and data analysis for array comparative
genomic hybridization. Cancer Invest. 26, 923–928.
Poteete, A.R. (2011). Recombination phenotypes of Escherichia coli greA mu-
tants. BMC Mol. Biol. 12, 12.
Prather, D.M., Larschan, E., and Winston, F. (2005). Evidence that the elonga-
tion factor TFIIS plays a role in transcription initiation at GAL1 in
Saccharomyces cerevisiae. Mol. Cell. Biol. 25, 2650–2659.
Putnam, C.D., Allen-Soltero, S.R., Martinez, S.L., Chan, J.E., Hayes, T.K., and
Kolodner, R.D. (2012). Bioinformatic identification of genes suppressing
genome instability. Proc. Natl. Acad. Sci. USA 109, E3251–E3259.
Quinlan, A.R., and Hall, I.M. (2010). BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26, 841–842.
Reines, D. (1992). Elongation factor-dependent transcript shortening by tem-
plate-engaged RNA polymerase II. J. Biol. Chem. 267, 3795–3800.
Saeki, H., and Svejstrup, J.Q. (2009). Stability, flexibility, and dynamic interac-
tions of colliding RNA polymerase II elongation complexes. Mol. Cell 35,
191–205.
Santos-Pereira, J.M., and Aguilera, A. (2015). R loops: new modulators of
genome dynamics and function. Nat. Rev. Genet. 16, 583–597.
Saponaro, M., Kantidakis, T., Mitter, R., Kelly, G.P., Heron, M., Williams, H.,
So¨ding, J., Stewart, A., and Svejstrup, J.Q. (2014). RECQL5 controls transcript
elongation and suppresses genome instability associated with transcription
stress. Cell 157, 1037–1049.
Schultz, L.B., Chehab, N.H., Malikzay, A., and Halazonetis, T.D. (2000). p53
binding protein 1 (53BP1) is an early participant in the cellular response to
DNA double-strand breaks. J. Cell Biol. 151, 1381–1390.
Schwalb, B., Michel, M., Zacher, B., Fr€uhauf, K., Demel, C., Tresch, A.,
Gagneur, J., and Cramer, P. (2016). TT-seq maps the human transient tran-
scriptome. Science 352, 1225–1228.
Sheridan, R.M., Fong, N., D’Alessandro, A., and Bentley, D.L. (2019).
Widespread backtracking by RNA Pol II is a major effector of gene activation,
5’ pause release, termination, and transcription elongation rate. Mol. Cell 73,
107–118.e104.
Sigurdsson, S., Dirac-Svejstrup, A.B., and Svejstrup, J.Q. (2010). Evidence
that transcript cleavage is essential for RNA polymerase II transcription and
cell viability. Mol. Cell 38, 202–210.
Skourti-Stathaki, K., Proudfoot, N.J., andGromak, N. (2011). Human senataxin
resolves RNA/DNA hybrids formed at transcriptional pause sites to promote
Xrn2-dependent termination. Mol. Cell 42, 794–805.
Sridhara, S.C., Carvalho, S., Grosso, A.R., Gallego-Paez, L.M., Carmo-
Fonseca, M., and de Almeida, S.F. (2017). Transcription dynamics prevent
RNA-mediated genomic instability through SRPK2-dependent DDX23 phos-
phorylation. Cell Rep. 18, 334–343.
Tuduri, S., Crabbe´, L., Conti, C., Tourrie`re, H., Holtgreve-Grez, H., Jauch, A.,
Pantesco, V., De Vos, J., Thomas, A., Theillet, C., et al. (2009).
Topoisomerase I suppresses genomic instability by preventing interference
between replication and transcription. Nat. Cell Biol. 11, 1315–1324.
Wang, D., Bushnell, D.A., Huang, X., Westover, K.D., Levitt, M., and Kornberg,
R.D. (2009). Structural basis of transcription: backtracked RNA polymerase II
at 3.4 angstrom resolution. Science 324, 1203–1206.Molecular Cell 76, 57–69, October 3, 2019 69
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Monoclonal to RNAPII phosphorylated CTD (4H8) The Francis Crick Institute Core
Facility
N/A
Monoclonal to CTD repeat RNAPII (8WG16) The Francis Crick Institute Core
Facility
N/A
Mouse monoclonal to S9.6 The Francis Crick Institute N/A
Polyclonal to N-terminal TFIIS (TCEA1) This paper N/A
Polyclonal to total RNAPII (N-20) Santa Cruz Sc-899; RRID: AB_632359
Monoclonal to Flag Sigma F1804; RRID: AB_262044
Monoclonal to Flag Sigma F3165; RRID: AB_259529
Polyclonal to Histone H2Ax Abcam ab11175; RRID: AB_297814
Histone gH2Ax Abcam ab2893; RRID: AB_303388
Monoclonal to Vinculin Sigma V9131; RRID: AB_477629
Monoclonal to ssDNA Milipore MAB3031; RRID: AB_10677396
Streptavidin-HRP Pierce 21130;
Polyclonal to 53BP1 Abcam ab36823; RRID: AB_722497
Polyclonal to 53BP1 Novus Biologicals NB100-304; RRID: AB_10003037
Monoclonal to Ubiquitin (P4D1) Cell Signaling 3936S; RRID: AB_10691572
Secondary Goat Anti-Mouse Alexa Fluor 594 ThermoFisher Scientific R37121; RRID: AB_2556549
Secondary Chicken Anti-Mouse Alexa Fluor 488 ThermoFisher Scientific A21200; RRID: AB_141606
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Li-Cor Secondary Donkey Anti-Rabbit 800CW Li-Cor 925-32213; RRID: AB_2715510
Li-Cor Secondary Donkey Anti-Mouse 680LT Li-Cor 926-68022; RRID: AB_10715072
Anti-mouse HRP Santa Cruz sc-516102; RRID: AB_2687626
Anti-rabbit HRP Jackson ImmunoResearch 711-035-152; RRID: AB_10015282
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NEB 5-alpha Competent E. coli NEB C2988J
Rosetta TM (DE3) E. coli Novagen 70954
Chemicals, Peptides, and Recombinant Proteins
5,6-Dichlorobenzimidazole 1-b-D-ribofuranoside (DRB) Sigma-Aldrich D1916
RNase H NEB M0297S
SuperaseTM ThermoFisher Scientific AM2694
Doxycycline Clonetech 8634-1
MG132 Cayman Chemical 10012628
N-Ethylmaleimide (NEM) Sigma-Aldrich E3876
DNase, RNase Free Promega M6101
5 Ethynyl-uridine Jena Bioscience CLK-N002-10
4-thiouridine Glentham Life Sciences GN6085
MTSEA biotin-XX linker (MTSEA Biotincapcap; 2-((6-((6-
((biotinoyl)amino)hexanoyl)amino)hexanoyl)amino)
ethylmethanethiosulfonate))
Biotium BT90066
Alexa Flour 488 Azide ThermoFisher Scientific A10266
Dynabeads Protein A/G ThermoFisher Scientific 10001D/3D
ANTI-FLAG M2 Affinity Gel Sigma-Aldrich A2220, RRID: AB_10063035
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
3xFLAG peptide Peptide Chemistry, The Francis
Crick Institute
N/A
TCEA1 peptides for N terminal antibody GPSTEKDLDEK
KKEPAITSQNSPC-CONH2 and AREESTSSGNVSNRKDE
TNARDTC- CONH2
Peptide Chemistry, The Francis
Crick Institute
N/A
Critical Commercial Assays
RNeasy Mini Kit Qiagen 74104
RNA minElute clean-up kit Qiagen 74204
QiAmp DNA mini kit Qiagen 51304
mMACS Streptavidin Kit Miltenyi 130-074-101
TruSeq HT kit Illumina 20020595
Strand specific TruSeq total RNA kit Illumina 20020597
KAPA RNA Hyper prep Illumina KR1350
Taqman Reverse Transcriptase Reagents ThermoFisher Scientific N8080234
Comet Assay Kit Trevigen N/A
Deposited Data
Sequencing data This study GEO: GSE132400
Mendeley dataset This study https://doi.org/10.17632/8hzcg3bk37.1
Experimental Models: Cell Lines
HEK293T-RExTM cell line Thermo Fischer Scientific R71007
HEK293T-Rex – TCEA1mut This study N/A
U2OS Thermo Fischer Scientific 920022711
U2OS-RNH1 Caldero´n-Montan˜o JM (CABIMER) N/A
Experimental Models: Organisms/Strains
Recombinant DNA
pcDNA4/TO (empty plasmid) ThermoFisher Scientific V102020
pET28aSUMO (empty plasmid) Kind gift from Peter Cherepanov N/A
pcDNA4/TO-TCEA1mut cDNA This paper N/A
pET28aSUMO-TCEA1WT cDNA This paper N/A
pET28aSUMO-TCEA1mut cDNA This paper N/A
Sequence-Based Reagents
See Table S4 N/A
Software and Algorithms
SAMtools Li et al., 2009 http://samtools.sourceforge.net/
BWA Li and Durbin, 2009 http://maq.sourceforge.net/
BEDtools Quinlan and Hall, 2010 https://bedtools.readthedocs.io/en/latest/
MISO Katz et al., 2010 http://genes.mit.edu/burgelab/miso/
DEXSeq Anders et al., 2012 http://bioconductor.org/packages/release/
bioc/html/DEXSeq.html
STAR version 2.5.2a Dobin et al., 2013 https://github.com/alexdobin/STAR
RSEM 1.2.31 Li and Dewey, 2011 https://github.com/deweylab/RSEM
DESeq2 Love et al., 2014 N/A
DAVID Bioinformatics resource Huang da et al., 2009a, 2009b https://david.ncifcrf.gov/
HCS Studio 2.0 Cell Analysis Software ThermoFisher Scientific https://www.thermofisher.com/order/
catalog/product/SX000041A
Other
High glucose DMEM ThermoFisher Scientific 11965118
Tet-free FBS Gibco 16000-044
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Poly-lysine Sigma Aldrich P7280
VECTASHIELD Antifade Mounting Medium containing
DAPI
Vector Laboratories H-1200
ProLong Gold Antifade Mounting Medium ThermoFisher Scientific P36930
3-8% Tris Acetate gels Bio-Rad 3450130
4-15% TGX gels (18 wells/26 wells) Bio-Rad 56711084/5
10% TBE-Urea gels Novex EC68755BOX
15% TBE-Urea gels Novex EC6885BOX
Complete EDTA-free protease inhibitor cocktail Sigma Aldrich 05056489001
Nitrocellulose membrane GE Healthcare Life Sciences 1060002
Amersham Hybond N+ membrane GE Healthcare Life Sciences RPN203B
PhosSTOP Sigma-Aldrich 4906837001
Benzonase MerckMillipore 70746-4
iTaqTM Universal SYBR Green Supermix Bio-Rad 172-5124
Lipofectamine 2000 Thermo Fischer Scientific 11668019
Proteinase K Sigma Aldrich 3115887001
AMPureXP beads Beckman Coulter A63881
T4 Polynucleotide Kinase ThermoFisher Scientific EK003
TRIzolTM Reagent ThermoFisher Scientific 15596026
Phenol/Chloroform pH 4.5 ThermoFisher Scientific AM9722
DynabeadsTM MyOneTM Streptavidin C1 ThermoFisher Scientific 65001
DecadeTM RNA markers system ThermoFisher Scientific AM7778
32 P-alpha ATP Perkin Elmer NEG003H250UC
32 P-gamma ATP EasyTide Lead Perkin Elmer NEG502A250UC
HiTrap TM Heparin SP FF column (1ml) GE Healthcare 17505401
Fast Flow Q Sepharose GE Healthcare 17051005
Amicon Ultra-15 15K MWCO spin concentrators MerckMillipore UFC900308LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents, such as plasmids, should be directed to and will be fulfilled by the Lead
Contact, Jesper Svejstrup (jesper.svejstrup@crick.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines and Culture Conditions
Human HEK293T-REx (Invitrogen) cells were grown at 37C, 5% CO2 in DMEM supplemented with 10% fetal bovine serum and 5%
penicillin/streptomycin. The Francis Crick Institute Cell Services department screened cell lines for mycoplasma contamination, and
authenticated species by STR profiling and PCR based analysis.
U2OS and U2OS-RNH1 (Tet-On system, Invitrogen) cells were maintained in DMEMmedium, supplemented with 10% heat-inac-
tivated fetal calf serum (FCS) and culture at 37C, 5% CO2. All cell lines have been confirmed to be mycoplasma-free.
METHOD DETAILS
Generation of Stable Cell Line
For generation of stable doxycycline-inducible TFIISmut cell lines, HEK293T-REx were transfected with pcDNA4/TO-TFIISmut
plasmid, expressing full length mutant TFIIS (TCEA1) under a tetracycline/doxycycline responsive promoter, and Zeocin-selected.
Colony Formation Assay
Cells stably expressing dox-inducible TFIISmut were seeded at a low density (200 cells/well) into 6-well plates n in the absence
or presence of doxycycline. Colonies were allowed to form over a 10-14 day period after which they were fixed by 4% (v/v)e3 Molecular Cell 76, 57–69.e1–e9, October 3, 2019
formaldehyde and stained with 0.1% (w/v) crystal violet. Colonies from two biological replicates (each seeded into triplicate wells)
were counted.
Immunofluorescence
Cells were grown onto poly-lysine (Sigma-Aldrich P7280) coated coverslips, fixed in 4% (v/v) formaldehyde and processed as pre-
viously described (Kantidakis et al., 2016). Briefly, the primary antibody, used in 1:1000 dilution was anti 53BP1 (Abcam, ab 36823)
and the secondary antibody anti-rabbit Alexa Fluor 594 (Life Technologies). The coverslips were mounted using Vectashield Antifade
MountingMedium containing DAPI (Vector Laboratories, H-1200) and visualized using a Zeiss fluorescent microscope with a 63x/1.4
oil immersion and quantified with ImageJ.
For R-loop detection, cells were grown on coverslips, fixed and permeabilized in 100% ice cold methanol and acetone for 10 min
and 1 min on ice, respectively, and processed as previously described (Sridhara et al., 2017). Briefly, the primary antibody, S9.6 was
used in 1:500 dilution, and the secondary antibody anti-mouse Alexa Fluor 594 (Life Technologies). The coverslips were mounted
using Vectashield AntifadeMountingMedium containing DAPI (Vector Laboratories, H-1200) and visualized using a Zeiss fluorescent
microscope with a 63x/1.4 oil immersion and quantified with ImageJ.
53BP1 Foci Analysis in U20S
For 53BP1 foci analysis in U2OS and U2OS-RNH1 (the latter a cell line stably integrating a Tet-on system to induce overexpression of
RNase H1 (kindly provided by Caldero´n-Montan˜o JM)), cells were plated onto coverslips and after 24 hours were transfected using
Lipofectamine 2000 with a plasmid to overexpress Flag-tagged TFIISmut or with a plasmid to overexpress luciferase as a mock con-
trol. Before transfection, the medium was replaced with fresh medium containing, or not, 5 mg/ml of doxycycline to induce RNase H1
overexpression in U2OS-RNH1 cells. Cells were fixed at 48 hours after transfection with 3.7% formaldehyde (v/v) in PBS for
15 minutes, washed 4 times with PBS, permeabilized with 0.5% Triton X-100/PBS for 5 minutes and blocked with 3% bovine serum
albumin (BSA) in PBS for 1 hour. The coverslips were then incubated with anti-53BP1 (Novus Biologicals) and anti-Flag (Sigma Al-
drich) antibodies diluted 1:500 in 3% BSA/PBS for 2 hours followed by 3 washes with PBS and 1 hour incubation with 1:1000 diluted
secondary antibodies conjugated with Alexa Fluor 488 (chicken anti-mouse) and Alexa Fluor 647 (goat anti-rabbit) (Invitrogen, cat.no
A21200 and A21244 respectively). After 2 washes with PBS, nuclei were counterstained with 10 mg/ml of DAPI in PBS for 5 minutes,
washed 3 more times and mounted with ProLong Gold antifade reagent (Invitrogen). Random images were acquired with a 63X
objective using a Leica DM6000 wide-field microscope. Data acquisition and image processing were performed using the LAS AF
software (Leica). Microscopy data analysis was performed using the Metamorph v7.5.1.0 software (Molecular Probes).
Alkaline Comet Assay
U2OS and U2OS-RNH1 cell lines were transfected as detailed above. Following 48 hours after transfection and RNase H1 induction,
comet assay was performed with a commercial kit (Trevigen, Gaithersburg, MD, USA) according to the manufacturer’s instructions.
Comet slides were stained with SYBR Green, and images were captured at 10X magnification using a Leica DM6000 wide-field mi-
croscope. Comet tail moments were analyzed using TriTek CometScore Professional (version 1.0.1.36) software. At least 100 cells
were scored in each experiment to calculate the median of the tail moment.
Western Blotting
For whole cell extracts, cell pellets were lysed in TENT cell lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.5%
Triton X-100, PhosSTOPTM (Sigma-Aldrich 04906837001) and Protease Inhibitor Cocktail). 40 mg protein/lane was separated by
SDS-PAGE on 4%–12% polyacrylamide gels and transferred onto nitrocellulose membrane (GE Healthcare Life Sciences
10600002). Membranes were blocked in 5% (w/v) skimmed milk in PBS-T (PBS 0.05% (v/v) Tween20) for 30 min are room temper-
ature and incubated with primary antibody in blocking buffer overnight at 4C. Primary antibodies are listed in Key Resources Table.
Membranes were washed several times in PBS-T, incubated with Li-Cor fluorescent dye-conjugated secondary antibodies or HRP-
conjugated secondary antibodies in blocking buffer and visualized.
Flag- and RNAPII-Immunoprecipitation – Extract Preparation
TFIISmut cells were cultured in the absence or presence of doxycycline for 48 hours. Phosphatase inhibitors (PhosSTOP
TM,
Sigma Aldrich) and Protease inhibitors (Sigma Aldrich) were added fresh to all buffers. A0.8mL cell pellet volumewas resuspended
in 2 pellet volumes (PVs) of hypotonic buffer (HB) buffer (10 mMHEPES pH 7.5, 10 mMKCl, 1.5 mMMgCl2). Cells were homogenized
in a Dounce homogenizer with 10 strokes loose pestle/pestle A and incubated on ice for 15 min. Nuclei were pelleted by
centrifugation at 3900 rpm for 15 min. The supernatant was removed and supplemented with glycerol to a final concentration of
0.05%, NaCl to a final concentration of 150 mM, and EDTA for a concentration of 3 mM. After centrifugation at 20000 g for
10 min, this cleared cytoplasmic fraction was kept for further analysis. The nuclei in the pellet were resuspended in 2 PVs of nucle-
oplasmic extraction buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 150 mM KCH3COO, 10% glycerol, 0.05% NP-40). Nuclei were
lysed by 15 strokes loose pestle/pestle A and incubated on ice for 20 min followed by centrifugation at 20,000 g for 20 min. The
nucleoplasmic supernatant was pooled with the cytoplasmic fraction and kept aside as the ‘soluble fraction’. The chromatin
pellet was resuspended in 1 mL chromatin digestion buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 10% glycerol, 150 mM NaCl,Molecular Cell 76, 57–69.e1–e9, October 3, 2019 e4
0.1% NP-40, 250 U benzonase/ml), incubated 45 min on ice and centrifuged for 20 min at 20,000 g. The supernatant was removed
and kept as ‘low salt chromatin fraction’. The remaining pellet was resuspended in 0.6 PV of 500 mMNaCl buffer (20 mM HEPES pH
7.9, 3 mM EDTA, 1.5 mMMgCl2, 10% glycerol, 500mMNaCl, 0.1%NP-40) and incubated 20min on ice. 1.4 PV of salt dilution buffer
(20 mM HEPES pH 7.9, 3 mM EDTA, 1.5 mMMgCl2, 10% glycerol, 0.1% NP-40) was added and centrifuged for 15 min at 20,000 g.
The supernatant was pooled with the low salt chromatin fraction and used for further affinity purifications.
Flag (M2)-Affinity Purification of TFIIS
The chromatin fractions were incubated with approximately 30 mL pre-equilibrated M2 anti-FLAG agarose beads (Sigma), rotating at
4C overnight. After incubation, the flow-through was collected and the beads were washed with 40 CV IP wash buffer (20 mM
HEPES pH 7.9, 1.5 mMMgCl2, 150 mM NaCl, 0.05% NP-40, 1x Protease inhibitor mix, PhosphoStop phosphatase inhibitor). Immu-
noprecipitates were eluted using 500 mg/ml 3x FLAG peptide (The Francis Crick Institute), dissolved in IP wash buffer, by incubation
for 30 min at 4C . 30 mL of elution fractions were subjected to SDS-PAGE and subsequently stained with Instant Blue Coomassie.
The stained proteins were excised from the polyacrylamide gel, cut into 8 equal slices and submitted to mass spectrometry analysis.
Proteins were in-gel digested with trypsin using a Janus Automated Workstation (Perkin Elmer) and peptides were analyzed using a
LTQ Orbitrap-Velos mass spectrometer coupled to an Ultimate3000 HPLC and equipped with an EASY-Spray nanosource
(ThermoFisher Scientific).
RNAPII Affinity Purification
The chromatin fractions were incubated with approximately 30 mL pre-equilibrated magnetic Dynabeads Protein A (Invitrogen)
coupled with 1 mg of RNAPII antibody (4H8) rotating at 4C overnight. After incubation, the flow-through was collected and the beads
were washed with 50 CV wash buffer (20 mMHEPES pH 7.9, 1.5 mMMgCl2, 150 mMNaCl, 0.05% NP-40, 1x Protease inhibitor mix,
PhosphoStop phosphatase inhibitor). Proteins (30 mL of elution fractions) were eluted by boiling in Laemmli loading buffer for 5 mi-
nutes at 95C, before being subjected to SDS-PAGE and subsequently stained with Instant Blue Coomassie. The stained proteins
were excised from the polyacrylamide gel, cut into 8 equal slices and submitted to mass spectrometry analysis. Proteins were in-gel
digested and subjected to mass spectrometry as above. The Proteomics Laboratory at Francis Crick Institute performed all mass
spectrometry analyses described in this study.
DSK2-Pulldown
DSK2 resin was prepared as previously described (Anindya et al., 2007). Briefly, Pull-down of ubiquitylated proteins was performed
by incubating 25 mL DSK2 resin with 500 mg WCE in 500 ml overnight at 4C. The beads were washed 4 times with 1ml TENT buffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.5% Triton X-100) for 5 min each. Afterward, the beads were resuspended in
100 mL 4xSDS loading buffer and boiled for 10 min at 95C. 15 mL of sample was used for SDS-PAGE and immunoblotting.
5-Ethynyl Uridine (EU) Transcription Assay
Cells were incubated for 48 hr with or without doxycycline. Media was replaced with fresh media containing 0.75 mM 5-Ethynyl uri-
dine (EU) and cells were incubated for different amount of time (30min, 60min, 90 min, 120 min, 180 min). EU-containing media was
removed and cells were fixed in PBS-buffered formaldehyde (3.7%) for 45 min at room temperature, washed once with PBS using a
plate washer, followed by permeabilization with 0.5% TX-100 diluted in PBS for 30 min. Permeabilized cells were washed once with
PBS, and then Alexa Fluor 488 Azide fluorophores were covalently attached to the EU-containing nascent RNA by click reaction
(100 mM Tris pH 8.5, 4 mMCu2SO4, 10 mMAlexa azide 488, 100 mMAscorbic Acid) for 1 hr at room temperature. Cells were washed
3 times in 100 mM Tris, pH 7.5 and stained with DAPI (40,6-diamidino-2-phenylindole dihydrochloride) at a final concentration of
1 mg/ml. Cells were washed once with PBS. Automated image acquisition of 6 fields per well was performed (Cellomics Array
Scan VTI, ThermoFisher Scientific) using a 10X objective.
Image analysis was performed using HCS Studio 2.0. Cell nuclei were masked using the DAPI staining. The average intensity of
Alexa Fluor 488-conjugated EU-labeled RNA was measured for each nucleus in at least 3 separate wells and plotted.
ChIP-Sequencing
For chromatin-immunoprecipitation (ChIP) experiments, cells were harvested by trypsin-treatment and fixed in suspension with
formaldehyde, 1% final concentration, for 10 min at room temperature, with rotation. The crosslinking reaction was quenched
with glycine (125 mM final concentration) for 5 min. Cells were washed twice with ice-cold 1 3 PBS and lysed in 1 mL of ChIP
cell lysis buffer (5 mM HEPES pH 8.0, 85 mM KCl, 0.5% NP-40, and protease inhibitors) and incubated 5 min on ice. Nuclei were
pelleted by centrifugation at 3,900 g for 5 min at 4C. Finally, nuclei were lysed in ChIP nuclear lysis buffer (50 mM Tris-HCl pH
8.1, 10 mM EDTA (pH 8.0), 1% SDS, and protease inhibitors) and incubated 5 min on ice. Nuclear lysate was sheared by using an
ice-water bath-embedded Bioruptor sonication system at high power, 30 s on, 30 s off mode for 5–10 min. The size of the sheared
DNA was checked by 2% agarose gel electrophoresis to be between 300–600 base pairs (bp). Sonicated chromatin was cleared by
centrifugation at 20,000 g for 15 min at 4C. Before the immune-precipitation, chromatin was diluted 1:5 with ChIP dilution buffer
(0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA (pH 8.0), 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl and protease inhibitors). 1 mg of
RNAPII antibody (4H8; recognizes all forms of RNAPII), or 1 mg of mouse IgG (Sigma), was bound to 15 mL of Protein A Dynabeadse5 Molecular Cell 76, 57–69.e1–e9, October 3, 2019
(Invitrogen) in 200 mL 5%BSA in PBS for 1 hr (h), before being washed twice with 500 mL of the same buffer. The sonicated chromatin
was incubated with the antibody-conjugated beads overnight (o/n) at 4Cwith rotation. Beads were washed twice with 1 mL of each
of the following buffers: ChIP low salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 150 mM NaCl); ChIP
high salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl); and ChIP LiCl buffer (10 mM Tris-
HCl pH 8.0, 250 mM LiCl, 1%NP-40, 1% deoxycholic acid, and 1 mM EDTA). Beads were washed once with 1 mL of TE buffer (pH 8)
and centrifuged for 1 min at 14,000 g before removing the buffer. Beads were finally suspended in 40 mL Elution Buffer (50 mM Tris-
HCl pH 8.0, 10 mM EDTA, 1% SDS) and incubated at 65C for 15 min. The eluted ChIP material was incubated at 65C o/n to revert
the crosslinking with an additional 90 mL of TE 13 /SDS1% and 1 mL 10 mg/ml RNase A. In parallel, the whole-cell extract was also
RNase treated and reverse crosslinked o/n at 65C. Proteinase K (100 mg) and Glycogen (20 mg) were added to the eluted ChIP ma-
terial and incubated for 2h at 37C, and DNA was twice extracted with phenol-chloroform-alcohol isoamylic acid, and precipitated
with ethanol/NaCl. Precipitated DNA was submitted for further manipulation by standard ChIP-seq library preparation techniques
(Illumina) and Advanced Sequencing on an Illumina HiSeq 2500 DNA sequencer. 51 bp single-end reads were Illumina adaptor
trimmed using cutadapt 2.7.12 (-e 0.1 –a AGATCGGAAGAGC –q 20,20) to a minimum length of 30bp prior to alignment to the
GRCh38 genome assembly using BWA mem 0.12.7 (Li and Dewey, 2011) with default settings. BAM files were sorted and indexed
using Picard. Further analysis was conducted using Bioconductor (Gentleman et al., 2004).
mRNA-Sequencing
Cell were induced for 48 hours before RNAwas extracted using RNeasy Kit (QIAGEN 74104) according to themanufacturer’s instruc-
tion including the on-column DNase treatment. 2 mg total RNA was used for purification and analyzed on a 2100 Bioanalyzer (Agilent
Technologies). All samples had an RIN value of greater than 8. The purified RNA was used for the preparation of Poly(A)-selected
mRNA libraries using the TruSeq RNA sample preparation kit and sequenced on an Illumina HiSeq 4000 as 101bp paired-end reads.
TT-Seq (Nascent RNA-Seq)
TFIISmut cells were cultured for 48 hours in the absence or presence of doxycycline. 4-thioridine (4SU) was added directly to the tissue
culture media to a final concentration of 1 mM, for 20 min. The reaction was stopped by removing the media and 1ml of TRIZOL re-
agent was added on top of the cells, followed by Phenol/Chloroform/Isoamyl alcohol (25:24:1) (Thermo Fisher Scientific) purification.
RNA was precipitated by addition of 1.1 volume of isopropanol and incubated at room temperature (RT) for 20 min. The pellet was
resuspended in 100 mL RNase-free water and the RNA concentration was measured using Qubit BR RNA assay. 100 mg of human
RNA was mixed with 1 mg S. cerevisiae spike-in RNA (strain BY4741, MATa, his3D1, leu2D0, met15D0, ura3D0) 4-thiouracil (4TU)-
labeled RNA, in a total volume of 100 ml. In order to fragment the RNA, 20 mL of 1M NaOH was added and incubated 20 min on ice.
Fragmentation was stopped by addition of 80 mL 1M Tris pH 6.8 and the reaction was cleaned by running it twice onMicro Bio-SpinTM
P-30 Gel Columns (BioRad 732-6223) spin columns according to the manufacturer’s instructions. The RNA was biotinylated by add-
ing MTSEA biotin-XX linker (Bioutium, BT90066) and incubating the reaction for 30 min at RT in the dark. The biotinylated RNA was
Phenol/Chloroform/Isoamyl alcohol purified, followed by ethanol-precipitating the RNA. 4SU incorporation was measured by drop-
ping 5 mL of diluted RNA (2:5) onto a N+ membrane (GE Healthcare Life Sciences), UV crosslinked twice at 2000 mJ and blocked for
20 min at RT in blocking buffer (10% SDS, 1mM EDTA in 1xPBS). Membrane was probed with 1:50,000 dilution of 1 mg/ml strepta-
vidin-horseradish peroxidase (Pierce) in blocking solution for 15 min. The membrane was washed six times in PBS, containing
decreasing concentrations of SDS (10%, 1% and 0.1%, each applied twice). The signal of biotin-bound HRP was visualized by
ECL detection.
4SU biotinylated RNA was further purified using the mMACS Streptavidin MicroBeads (Miltenyi, 130-074-101). Labeled RNA was
eluted by the addition of 100 mL freshly prepared 100mMDTT, followed by a second elution round 5min later. RNAwas recovered by
using the RNeasy MinElute Spin columns (QIAGEN, 74204). RNA was eluted in 15 mL RNase free water and 1 mL was analyzed on a
2100 Bioanalyzer with the mRNA pico settings (Agilent Technologies). cDNA libraries were prepared from the purified RNA by using
the KAPA RNA Hyper Prep kit and sequenced on an Illumina HiSeq 4000 as 76 bp single-end reads.
Reverse Transcriptase Quantitative PCR
RNeasyMini Kit (QIAGEN, 74104)-purified RNAwas used to generate randomhexamer primed cDNA libraries using TaqmanReverse
Transcriptase Reagents (Thermo Fischer Scientific, N8080234). Quantitative PCR were performed using iQ SYBR green Mastermix,
0.3 mM primer concentration and 1 mL of cDNA library per reaction. Reference gene-normalized RNA expression was compared be-
tween TFIISmut and parental samples using the Livak equation (Livak and Schmittgen, 2001). For example, tomeasure the expression
of different genes, the following equation was used (2^-((CTgene-CTGAPDH)TFIISmut-(CTgene-CTGAPDH)Parental)). Primer sequences are
found in Table S3.
DNA-RNA Slot Blot
Genomic DNA was isolated by using the QIAmp DNAMini kit (QIAGEN, 51304). Genomic DNA (175ng) was treated with 2U of RNase
H (NEB,M0297S) per mg of DNA for 2 hours at 37Cbefore loading on the slot blot and transferred onto a N+membrane. Following UV
crosslinking at 1200 mJ, membranes were blocked in 5% Milk/PBS-Tween (0.05% Tween20) and incubated overnight with S9.6
antibody (1:1000). After the last wash, the membrane was incubated for 1 hour at RT with secondary antibody (goat anti mouseMolecular Cell 76, 57–69.e1–e9, October 3, 2019 e6
horseradish peroxidase). After washing three times for 10 min with PBS-Tween (0.05% Tween20), the membrane was briefly dried
and incubated with SuperSignal West Pico chemiluminescent substrate (Thermo Fischer Scientific) for 2minutes. The chemilumines-
cent signal was detected by exposure of the membrane to Amersham Hyperfilm ECL (GE Healthcare). To determine the loading, the
membrane was washed twice for 10 min in PBS-Tween (0.05% Tween20) and denatured with 0.5N NaOH, 1.5M NaCl for 10 min at
RT, followed by 10 min incubation with 1M NaCl, 0.5 M Tris pH 7. After one wash with PBS-Tween (0.05% Tween20) the membrane
was incubated for 2 hours at RT with ssDNA antibody (Milipore, MAB3031), and detection was carried out as above.
DNA-RNA Hybrid Mapping (DRIP)
DRIP-qPCR experiments were performed similar to the protocol described in (Sridhara et al., 2017) with the following modifications.
Briefly, nucleic acids were extracted using standard phenol-chloroform extraction and re-suspended in DNase/RNase-free water.
Nucleic acids were fragmented using a restriction enzyme cocktail (20U each of EcoRI, BamHI, HindIII, BsrgI and XhoI (NEB)).
Half of the sample was digested with 40U RNase H (NEB) to serve as negative control, for 24 hours at 37C. Digested nucleic acids
were cleaned with phenol-chloroform extraction and re-suspended in DNase/RNase-free water. RNA-DNA hybrids were immuno-
precipitated from total nucleic acids using 5 mg of the S9.6 antibody in binding buffer (10 mM NaPO4, pH 7, 140 mM NaCl, 0.05%
Triton x-100) overnight incubation at 4C with 50 mL protein A/G magnetic beads (Thermo Fischer Scientific). Isolated complexes
were washed three times with binding buffer and once with TE buffer for 10 min at RT, before elution with 500 ml of elution buffer
(50mMTris pH 8, 10mMEDTA, 0.5%SDS). Proteinase K digestionwas performed for 30min at 55C, followed by phenol-chloroform
extraction as before. Pellet was air-dried and resuspended in 100 mL DNase/RNase free water. The DNA was further used to deter-
mine the relative occupancy of the immunoprecipitated DNA-RNA hybrid by RT-qPCR and analyzed with the primers described in
Table S4.
Recombinant Protein Expression and Purification
RosettaTM BL-21 (DE3) E.coli cells were transformed with expression plasmid pET28aSUMO-TFIISWT or pET28aSUMO-TFIISmut and
selected with 50 mg/ml kanamycin. 1L E.coli cultures were grown to an optical density (OD600nm) of 0.6. TFIIS protein expression was
induced with 0.5 mM IPTG and the culture was shifted to 30C for 4 hours. Cell pellets were resuspended in 50mL lysis buffer (25mM
HEPES pH 7.9, 250 mM NaCl, 0.4% Triton X-100, 10% glycerol, 1 mM DTT,15 mM imidazole, 10 mMZnCl) and left for 20 min on ice.
Extracts were sonicated for 2 min at 30% amplitude, in 5 s bursts on ice, followed by ultracentrifugation at 45K for 30 min at 4C in a
70Ti rotor (Beckman Coulter). 4 mL Nickel NTA resin was washed with water by using a peristaltic pump and then with lysis buffer to
equilibrate (5 CV at 1 ml/min). Lysates were loaded at 0.5 ml/min in the cold room, followed by washing with 40 mL lysis buffer at
1 ml/min. Proteins were eluted with 25 mL elution buffer (25 mM HEPES pH 7.9, 10% glycerol, 500 mM NaCl, 1 mM DTT,
500 mM imidazole, 10 mM ZnCl) at 0.5 ml/min. Load, flow-through and elutions were resolved by running on an SDS-PAGE gel
and stained with Instant Blue Coomassie. Following addition of 7 mL of Ulp1 (22 mg/mL) to remove the SUMO tag, the eluates
(25 ml) were dialyzed (3.5 kD MWCO, diameter 29 mm) overnight at 4C against 1L of dialysis buffer (100 mM NaCl, 10% glycerol,
25 mM HEPES pH 7.9, 10 mM ZnCl, 1 mM DTT). The dialyzed sample was further purified by loading it via a 50 mL Superloop (GE
Healthcare) onto a 1mL HiTrap Heparin SP FF column (GE Healthcare). Fractions were eluted with a gradient from 100 to 400 mM
NaCl in 0.5ml fractions and resolved by SDS-PAGE gel as before. Fractions containing TFIIS were pooled and concentrated to a vol-
ume of approximately 4mL using an Amicon Ultra-15 15K MWCO spin concentrators (Millipore).
Yeast proteins were prepared as described in (Sigurdsson et al., 2010).
Purification of Bovine Pol II
Bovine RNAPII was prepared as previously described (Hu et al., 2006) with modifications. Unless otherwise noted, all steps were
completed at 4 C. Calf thymus was homogenized for 3 min in buffer A (50 mM Tris, pH 7.9 at 4 C, 10 mM ZnCl2, 10% glycerol, pro-
tease inhibitors (Sigma Aldrich)) using a 2L blender (Waring). The homogenized material was centrifuged and the supernatant filtered
through two layers of Bioprep nylon filter cloth. A 10% solution of polyethyleneimine, pH 7.8 at 25 C, was added to a final concen-
tration of 0.05%, and the material was stirred for 30 min, then centrifuged for 30 min at 12,000g. The resulting pellets were re-dis-
solved in buffer B (50 mM Tris, pH 7.9 at 4 C, 10 mM ZnCl2, 10% glycerol, 150 mM (NH4)2SO4, protease inhibitors (Sigma Aldrich)).
After centrifugation, the supernatant was loaded on a 120 mL Fast Flow Q Sepharose (GE Healthcare) column, equilibrated in buffer
B, by using a peristaltic pump at 5 ml/min. The column was washed with three column volumes of buffer B, followed by step-elution
with buffer C (50 mM Tris, pH 7.9 at 4 C, 10 mM ZnCl2, 500 mM (NH4)2SO4, protease inhibitors). The material was further purified
using a 5mL gravity flow column of 8WG16 (aRPB1 CTD) antibody-coupled Sepharose. The input was loaded overnight using a peri-
staltic pump at 0.1ml/min. After application of the input material, the antibody columnwas washedwith ten column volumes of buffer
C, sealed, and allowed to equilibrate to room temperature (20–25 C) for 15 min. RNAPII was eluted in batch using elution buffer (40%
1,2 propanediol, 500 mM (NH4)2SO4, 50 mM Tris pH7.8, 10 mM ZnCl2), collecting 4x 10 mL fractions at room temperature. The
RNAPII-containing fractions were dialyzed against dialysis buffer (50 mM Tris pH 7.8, 10 mM ZnCl2, 5 mM DTT, 10% glycerol,
150 mM (NH4)2SO4) and concentrated using a 100-kDa cut-off Amicon concentrator to a final concentration of 2–4 mg ml
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Oligonucleotides for In Vitro Transcription
DNA oligo 1 (transcribed strand):
50-GAGTTGGTTATGGTAGGTGAGTGTGTGATTGTGTGTTAGTGTGGTG-
TACCCTTGGGTTCTCTTTTCGCCTTGGGGGCTCCTCCTCCCTCCCTCTTTCCTGATGGCTGTTTGTTTCCTATAGCGTAGGCCT
TAGACAATTGCGCATTCAGAC-30
DNA oligo 2 (non-transcribed strand, biotinylated):
50-GTCTGAATGCGCAATTGTCTAAGGCCTACGCTATAGGAAACAAACAGCCATCAGGAAAGAGGGAGGGAGGAGGAGCCCC
CAAGGCGAAAAGAGAACCCAAGCGACACTTCATTAACACACAATCACACACTCACCTACCATAACCAACTC-30*
DNA oligo 3 (transcribed strand):
50-GGCCGGGTAACCCCCGTGTGGAGATGGGTGAGAGATGTTGAGGGCCTGGTCGTTTCCTATAGTTTGTTTCCT-30
DNA oligo 4 (non-transcribed strand, biotinylated):
* 50-CTAGAGGAAACAAACTATAGGAAACGACCAGGCCCTCAACATCTCTCACCCATCTCCACACGGGGGTTACCCGGCCTG
CA-30
RNA oligo 1 (unlabeled or 50-FAM labeled):
UUU UUA CAG CCA UC
RNA oligo 2 (50-FAM labeled):
UGCAUUUCGACCAGGCTranscript Cleavage Experiments
Elongation complexes (ECs) were reconstituted essentially as previously described (Saeki and Svejstrup, 2009) in a step-likemanner.
Briefly, a DNA-transcribed strand oligo was incubated at 75C for 5 min, followed by cooling on ice for 5 min. Next, an RNA oligo-
nucleotide was added and incubated for 5 min at room temperature (RT) to allow formation of the DNA/RNA hybrid. 1.5 ug
RNAPII was incubated with 2.5 pmol of the DNA/RNA hybrid for 20 min at RT, followed by the addition of 5 pmol of non-transcribed
DNA strand (which was typically biotinylated at the 30 end) and incubation at 37C for 10min. Assembled elongation complexes (ECs)
were purified by binding to streptavidin beads via biotin on the non-transcribed strand, followed bywashing in TB (40mMKCl, 20mM
Tris pH 7.9, 5 mMDTT, 20 uM ZnCl2, 7 mMMgCl2). Radiolabeling was carried out by adding P
32-alpha ATP for 5 min, before starting
further transcript elongation. Transcription was performed in TB for 5 min at RT in the presence of 500 mM each of ATP, GTP, UTP up
to the first guanine position in the template. After washing away free nucleotides (leading to RNAPII backtracking), ECs were incu-
bated for 30 min with either buffer alone or recombinant TFIIS protein. Reactions were stopped by the addition of stop buffer (20 mM
Tris pH 7.9, 0.2%SDS, 50mMEDTA, proteinase K) followed by incubation at 37C for 30min. After phenol/chloroform extraction and
ethanol precipitation, samples were resuspended in 95% formamide buffer containing 5mMEDTA and 0.1%SDS and RNA products
were resolved by 8 or 10% denaturing PAGE. Radioactive or FAM labeled bands were visualized by typhoon FLA 9500.
In Vitro R-Loop Formation Experiments
For R-loop formation experiments, the RNA oligonucleotide was either P32-50 end labeled or 50-FAM labeled (FAM labeled oligo pur-
chased from IDT) and then annealed to the DNA template strand (DNA oligo 1). For these experiments, 1.5 mg of yeast RNAPII was
incubated with 2.5 pmol of the DNA/RNA hybrid, followed by the addition of 5 pmol of the non-template DNA strand (which was bio-
tinylated at the 30 end), as previously described (Saeki and Svejstrup, 2009). The ECs were immobilized and washed as above. Tran-
scription was performed in TB (40 mM KCl, 20 mM Tris pH 7.9, 5 mMDTT, 20 mMZnCl2, 7 mMMgCl2) for 5 min at room temperature
(RT) in the presence of 500 mMeach of ATP, GTP, CTP up to the first adenine position in the template, generating a 69-nucleotide (nt)
product. Unincorporated nucleotides were removed by sequential washes with TB. WT-TFIIS and TFIISmut were added for 3 min,
followed by addition of 5U of RNase H (NEB, M0297S) and incubated at RT for 30 min. For the experiment shown in Figure S4E,
the TEC/DNA scaffolds were purified via the biotin-tag on the non-transcribed strand after RNase H treatment to ensure that only
anterior R-loops were detected (the label on posterior R-loops is released into the supernatant fraction due to RNase H cleavage).
Reactions were stopped by the addition of stop buffer (20 mM Tris pH 7.9, 0.2% SDS, 50 mM EDTA, proteinase K) followed by in-
cubation at 37C for 10 min. After phenol/chloroform extraction and ethanol precipitation, samples were resuspended in 95% form-
amide buffer containing 5mMEDTA and 0.1%SDS andwere resolved by 15% denaturing PAGE. Radioactive or FAM labeled bands
were visualized by typhoon FLA 9500.
N-Terminal TFIIS Antibody Production
An N-terminal TCEA1-specific antibody was raised against a mixture of two peptides:
hsTCEA1 79-101C GPSTEKDLDEKKKEPAITSQNSPC-CONH2
hsTCEA1 103-125C AREESTSSGNVSNRKDETNARDTC-CONH2Molecular Cell 76, 57–69.e1–e9, October 3, 2019 e8
Eurogentec were responsible for antibody production, using their 28-days Speedy protocol. Based on the analysis of the pre-im-
mune sera, two rabbits were selected for further immunizations. Each rabbit was injected with 250 mg of the peptidemixture. The final
bleeds were analyzed by western blot for specificity and yield
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using GraphPad Prism 6.0e software or Excel Microsoft and the tests described in the figure
legends.
BigWig Files
Genome coverage bigWig files were generated by converting BAM files to bedGraph format using BEDtools’ (Quinlan and Hall, 2010)
genomeCoverageBed function (-bg –split –scale 1) bedGraph files were in turn converted to bigWig format using the
bedGraphToBigWig function from the KentTools (Kent et al., 2010) package.
mRNA Differential Expression Analysis
Reads were aligned against GRCh38 and Ensembl release 86 transcript annotations using STAR v2.5.2a (Dobin et al., 2013) via the
transcript quantification software RSEM 1.2.31 (Li and Dewey, 2011). Resulting genome alignment BAM files were sorted and in-
dexed using Picard 2.1.1. The estimated counts per gene across all samples was used to assess differential expression between
parental and mutant cell lines via the R package DESeq2 (Love et al., 2014). An FDR % 0.01 and fold-change of at least ± 2 was
used to threshold significance.
mRNA-Seq Alternative Isoform Analysis
MISO (Mixture of Isoforms) 0.5.3 was used to identify transcript isoforms differentially regulated between mutant and parental cell
lines (Katz et al., 2010). Results were filtered for significance based on a Bayes factor > = 10 and dPSI > = +/0.2. Additionally, a
further filter for an inclusion count of > = 1, exclusion count of > = 1 and a sum of inclusion and exclusion counts > = 10 was applied.
Significant ALE events called in at least 2/3 replicates were selected for further analysis of terminal exon relative expression. A ratio
of proximal and distal exon reads-per-kilobase (RPK) was calculated for each mutant and parental sample. The mutant ratios were
normalized to the parental ratios and a mean of this score was calculated across replicates. A large positive score indicates a pref-
erence for the proximal exon in the mutant sample relative to the parental.
TT-Seq Metagene Profiles
Reads were aligned to the GRCh38 genome assembly using STAR 2.5.2a (Li and Durbin, 2009) with default settings. BAM files were
sorted and indexed using Picard. ngs.plot software (Katz et al., 2010) was used to generate read coverage profiles over the TSS
region 0kb:+120kb of all Ensembl protein coding genes from standard chromosomes (n = 19,919) with the following settings: -L
2000 –F chipseq –R bed. A subset of genes > = 60kb in length was used to create similar profiles over ‘‘long’’ genes (n = 2,875).
DATA AND CODE AVAILABILITY
The accession number for all sequencing data reported in this study is GEO: GSE132400. The raw data used in this study have been
deposited to Mendeley data and are available at https://doi.org/10.17632/8hzcg3bk37.1 .e9 Molecular Cell 76, 57–69.e1–e9, October 3, 2019
